表紙
市場調查報告書

CDMO - 全球市場的機會及競爭情形

Global Market Opportunities and Competitive Landscape for CDMO

出版商 BCC Research 商品編碼 954662
出版日期 內容資訊 英文 56 Pages
訂單完成後即時交付
價格
CDMO - 全球市場的機會及競爭情形 Global Market Opportunities and Competitive Landscape for CDMO
出版日期: 2020年08月19日內容資訊: 英文 56 Pages
簡介

CDMO (醫藥品受託製造開發機關) ,是提供服務供應商豐富的成長機會的進化產業。 CDMO產業走向整合。因此,CDMO企業發展成為整合的醫藥品服務供應商或一站式作業解決方案供應商。

本報告提供全球CDMO (醫藥品受託製造開發機關) 市場相關調查,市場規模的成果、預測、年複合成長率預測,市場潛力機會,目前趨勢與未來預測,法規相關最新資訊,及形成全球市場的其他宏觀經濟要素等相關討論,主要企業的簡介。

第1章 簡介

  • 報告的範圍
  • 資訊來源
  • 調查手法
  • 市場規模估計與預測模式
  • 地理明細
  • 分析師的經歷
  • BCC自訂調查
  • BCC Research 相關報告

第2章 彙整和亮點

第3章 醫藥品受託開發外包的背景

  • 外包的優點
  • 外包的缺點
  • CDMO結構
  • 受託製造服務(CMS)
  • 契約臨床開發服務

第4章 CDMO市場形勢

  • 市場動態
  • 促進因素
  • 課題和威脅
  • CDMO市場
  • 市場明細:各服務形式
  • 市場明細:各分子類型
  • 市場明細:各最終用途
  • 市場明細:各地區

第5章 CDMO法規

  • 美國的法規
  • 歐洲的法規

第6章 競爭情形

  • 概要
  • 市場佔有率分析:各比率、收益
  • 經營模式
  • 專門性的服務
  • 整合型服務
  • CDMO採用的策略
  • 擴張/投資
  • 整合/收購
  • 技術的升級
  • 最近的產業活動
  • 主要的收購
  • 主要的擴張活動

第7章 企業簡介

  • ABBVIE CONTRACT MANUFACTURING
  • AEONOVA GROUP
  • ALBANY MOLECULAR RESEARCH INC.
  • CAMBREX CORP.
  • CATALENT INC.
  • CHARLES RIVER LABORATORIES
  • CORDEN PHARMA SWITZERLAND LLC
  • DELPHARM
  • EVOTEC AG
  • FAMAR S.A.
  • FAREVA GROUP
  • PATHEON N.V.
  • PFIZER CENTREONE
  • LONZA GROUP
  • RECIPHARM AB
  • SIEGFRIED AG
  • VETTER PHARMA INTERNATIONAL GMBH
  • WUXI APPTEC
目錄
Product Code: PHM238A

Highlights:

CDMO is an evolving industry with abundant growth opportunities for service providers. CDMO industry is trending towards consolidation; thus, CDMO companies are evolving as integrated pharmaceutical service providers or one-stop solution providers. This report provides details on the CDMO industry including the future trends and latest developments.

Report Includes

Descriptive overview of the global pharmaceutical contract development and manufacturing organization (CDMO) market within the industry

Analyses of the global market trends, with data corresponding to market size for 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025

Discussion of the market potential and opportunities for pharmaceutical CDMO, current trends and future prospects, regulatory updates, and other macroeconomic factors shaping global marketplace

Identification of the pharma companies that are considered as leaders in their field, as well as technological means these companies are using to exploit their markets and dominate the market in their fields

Competitive landscape of the global CDMO market featuring companies with potential profitability in contracting with a CMO (contract manufacturing outsourcing) for both clinical and commercial stage manufacturing, and market share analysis of the top 20 CDMO companies

Profile description of the major pharmaceutical companies

Report Scope:

This report provides an overview of the pharmaceutical industry and the role contract development and manufacturing organizations (CDMO) play in it. This analysis includes a review of the global CDMO market by-service type, drug molecule type and end use. This report limits the CDMO market landscape to the US and European regions, and analyzes their regulatory policies, standards and inspection trends. The report also analyzes the competitive landscape, key competitors, key leaders, and the CDMO industry's top 20 manufacturers.

Report Includes:

  • Descriptive overview of the global pharmaceutical contract development and manufacturing organization (CDMO) market within the industry
  • Analyses of the global market trends, with data corresponding to market size for 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Discussion of the market potential and opportunities for pharmaceutical CDMO, current trends and future prospects, regulatory updates, and other macroeconomic factors shaping global marketplace
  • Identification of the pharma companies that are considered as leaders in their field, as well as technological means these companies are using to exploit their markets and dominate the market in their fields
  • Competitive landscape of the global CDMO market featuring companies with potential profitability in contracting with a CMO (contract manufacturing outsourcing) for both clinical and commercial stage manufacturing, and market share analysis of the top 20 CDMO companies
  • Profile description of the major pharmaceutical companies

Table of Contents

Chapter 1: Introduction

  • Scope of Report
  • Information Sources
  • Methodology
    • Market Size Estimation and Forecast Model
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Contract Development Outsourcing Background

  • Outsourcing Benefits
  • Outsourcing Drawbacks
  • CDMO Structure
    • Contract Manufacturing Services (CMS)
    • Contract Clinical Development Services

Chapter 4: CDMO Market Landscape

  • Market Dynamics
    • Drivers
    • Challenges and Threats
  • CDMO Market
    • Market Breakdown by Type of Service
    • Market Breakdown by Type of Molecule
    • Market Breakdown by End Use
    • Market Breakdown by Region

Chapter 5: CDMO Regulations

  • US Regulation
  • European Regulation

Chapter 6: Competitive Landscape

  • Overview
  • Market Share Analysis by Percentage and Revenue
  • Business Models
    • Specialized Offerings
    • Integrated Offerings
  • Strategies Employed by CDMO
    • Expansion/Investment
    • Consolidation/Acquisition
    • Technology Upgradation
  • Recent Industry Events
    • Key Acquisitions
    • Key Expansion Activities

Chapter 7: Company Profiles

  • ABBVIE CONTRACT MANUFACTURING
  • AEONOVA GROUP
  • ALBANY MOLECULAR RESEARCH INC.
  • CAMBREX CORP.
  • CATALENT INC.
  • CHARLES RIVER LABORATORIES
  • CORDEN PHARMA SWITZERLAND LLC
  • DELPHARM
  • EVOTEC AG
  • FAMAR S.A.
  • FAREVA GROUP
  • PATHEON N.V.
  • PFIZER CENTREONE
  • LONZA GROUP
  • RECIPHARM AB
  • SIEGFRIED AG
  • VETTER PHARMA INTERNATIONAL GMBH
  • WUXI APPTEC

List of Tables

  • Summary Table: Global CDMO Market, by Type of Service, Through 2025
    • Table 1: Global CDMO Market, by Type of Service, Through 2025
    • Table 2: Global CDMO Market, by Type of Molecule, Through 2025
    • Table 3: Global CDMO Market, by End Use, Through 2025
    • Table 4: Global CDMO Market, by Region, Through 2025
    • Table 5: CDMO Industry Acquisitions/Consolidation Activities
    • Table 6: CDMO Industry Expansion Activities

List of Figures

  • Summary Figure: Global CDMO Market, by Type of Service, 2018-2025
    • Figure 1: Structure of CDMO
    • Figure 2: Market Segmentation of CDMO
    • Figure 3: Example of CDMO Services
    • Figure 4: Global CDMO Market, by Type of Service, 2018-2025
    • Figure 5: Global CDMO Market, by Type of Molecule, 2018-2025
    • Figure 6: Global CDMO Market, by End Use, 2018-2025
    • Figure 7: Global CDMO Market, by Region, 2018-2025
    • Figure 8: FDA cGMP Manufacturing Guidance Documents
    • Figure 9: FDA Site Inspections
    • Figure 10: European cGMP Guideline Documentation
    • Figure 11: European Site Inspection Outcomes
    • Figure 12: CDMO Competitor Landscape
    • Figure 13: CDMO Competitor Analysis, by Services
    • Figure 14: CDMO Top 22 Competitor Market Share Analysis
    • Figure 15: CDMO Top 22 Competitor Market Share Analysis
    • Figure 16: CDMO Business Models